PSNL Long Call Strategy
PSNL (Personalis, Inc.), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NASDAQ.
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities. The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center.
PSNL (Personalis, Inc.) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $567.5M, a beta of 1.97 versus the broader market, a 52-week range of 3.84-11.5, average daily share volume of 1.7M, a public-listing history dating back to 2019, approximately 228 full-time employees. These structural characteristics shape how PSNL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.97 indicates PSNL has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long call on PSNL?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current PSNL snapshot
As of May 15, 2026, spot at $6.40, ATM IV 109.30%, IV rank 21.15%, expected move 31.34%. The long call on PSNL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on PSNL specifically: PSNL IV at 109.30% is on the cheap side of its 1-year range, which favors premium-buying structures like a PSNL long call, with a market-implied 1-standard-deviation move of approximately 31.34% (roughly $2.01 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PSNL expiries trade a higher absolute premium for lower per-day decay. Position sizing on PSNL should anchor to the underlying notional of $6.40 per share and to the trader's directional view on PSNL stock.
PSNL long call setup
The PSNL long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PSNL near $6.40, the first option leg uses a $6.40 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PSNL chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PSNL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $6.40 | N/A |
PSNL long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
PSNL long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on PSNL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on PSNL
Long calls on PSNL express a bullish thesis with defined risk; traders use them ahead of PSNL catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
PSNL thesis for this long call
The market-implied 1-standard-deviation range for PSNL extends from approximately $4.39 on the downside to $8.41 on the upside. A PSNL long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current PSNL IV rank near 21.15% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PSNL at 109.30%. As a Healthcare name, PSNL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PSNL-specific events.
PSNL long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PSNL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PSNL alongside the broader basket even when PSNL-specific fundamentals are unchanged. Long-premium structures like a long call on PSNL are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current PSNL chain quotes before placing a trade.
Frequently asked questions
- What is a long call on PSNL?
- A long call on PSNL is the long call strategy applied to PSNL (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With PSNL stock trading near $6.40, the strikes shown on this page are snapped to the nearest listed PSNL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PSNL long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the PSNL long call priced from the end-of-day chain at a 30-day expiry (ATM IV 109.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PSNL long call?
- The breakeven for the PSNL long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PSNL market-implied 1-standard-deviation expected move is approximately 31.34%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on PSNL?
- Long calls on PSNL express a bullish thesis with defined risk; traders use them ahead of PSNL catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current PSNL implied volatility affect this long call?
- PSNL ATM IV is at 109.30% with IV rank near 21.15%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.